Page 8 - Best Doctors in Spain — Get an Online Consultation

Professional experience

• Complutense University, Madrid (1991–1997):
  Specialist in the Department of Functional Assessment and Research at the School of Sports Medicine and Physical Education .
• Medical Center of the Supreme Sports Council, Madrid (1992–2001):
  Consultant physician in the field of sports medicine.
• Medical Service of Real Madrid FC (2001–2013):
  Providing medical care to elite professional athletes.
• Royal Spanish Field Hockey Federation (2000–2001):
  Doctor of the national team.
• Medical Consultant for the Spanish Basketball Clubs Association (ACB, 2020–2022):
  Management of medical projects related to the prevention and treatment of injuries.
• Quirónsalud Group (since 2006):
  Co-director of the Departments of Rehabilitation, Physiotherapy and Sports Medicine at the Quirónsalud Madrid and Ruber Juan Bravo University Hospitals.

Scientific activity

• Specialization in sports cardiology since 1994 .
• Co-author of international clinical guidelines in sports cardiology.
• Member of the Sports Cardiology Core Group of the European Society of Cardiology (2014–2020) .
• Coordinator of the Sports Cardiology Group of the Spanish Society of Cardiology (2014–2018).
• Author of numerous scientific articles and chapters in specialized books.
• Regular speaker at national and international congresses on sports medicine and cardiology.

Teaching activities

• Associate Professor at the School of Sports Medicine, Complutense University (1992-2001).
• Lecturer at the Faculty of Medicine of the European University of Madrid (since 2012).

Key Skills and Achievements

• Many years of experience in medical support of athletes of various ages and training levels.
• Integration of advanced sports medicine techniques for the prevention, diagnosis and treatment of injuries.
• Contribution to the development of sports cardiology as a separate field.
• Ability to combine clinical practice, research and teaching to improve patient health.

The doctor actively uses his knowledge and many years of experience to provide the highest level of medical care to both professional athletes and amateurs.

Professional activity

Dr. Borja Núñez de Aysa is the Director of the Ultrasound Interventional and Biological Therapies Unit at Olympia Quirónsalud. His appointment is a major development in the field of sports medicine, promising to take the institution to a new level of quality of care.

Medical career:

• More than 20 years of experience working with professional and amateur athletes.
• Specialization in the treatment and diagnosis of musculoskeletal injuries using ultrasound interventionism and regenerative technologies.
• Working in the medical service of prestigious clubs such as Atletico Madrid and Real Madrid , which highlights his deep understanding of the needs of elite athletes.

Special achievements:

• A recognized expert in the field of regenerative medicine, including the use of plasma rich in growth factors (PRGF) and stem cells .
• Implementation of innovative treatment methods that take sports medicine to a new level.

Education and specialization

• Faculty of Medicine, University of Alcalá (UAH):
  Graduated with first prize in the Objective Structured Clinical Evaluation (ECOE).
• Specialization:
  • Residency in Physical and Rehabilitation Medicine at the Puerta de Hierro Hospital, Majadahonda.
  • Continuous training and advanced training in the field of ultrasound diagnostics and interventional medicine.

Scientific interests and achievements

• Research in the field of regenerative medicine and development of new methods for treating musculoskeletal injuries.
• Conducting seminars, master classes and publishing scientific articles in reputable medical journals.
• Active collaboration with leading specialists, including close cooperation with the Olympia Quirónsalud Physiotherapy and Traumatology Department, headed by Dr. Manuel Lles.

Key Skills and Achievements

• Treatment of all types of sports injuries using visual control methods (ultrasound).
• A unique approach that provides personalized treatment for each patient, from diagnosis to recovery and prevention.
• Combining advanced technology and deep clinical experience to achieve the best results.

Contribution to sports medicine

Dr. Nunes de Aysa and his team have created one of the most modern departments in Europe, offering innovative and highly effective treatment methods. His work not only helps athletes recover faster from injuries, but also sets new standards in medical practice, making quality treatment available to every patient.

*Bachelor of Medicine, University of Malaga, Spain.

*Specialist, Department of Ophthalmology, University Hospital Torrecardenas, Almeria. Spain.

*Follow-up, University Hospital Virgen de la Victoria, Malaga, Spain.

*Follow-up, University Hospital Ramon y Cajal, Madrid, Spain.

*Master of Cliniсal Ophthalmology, University CEU-Cardenal Herrera.

Areas of special interest and dedication in daily clinical practice:

-Cataract surgery (monofocal, toric, premium multifocal lenses)

-Strabismus surgery (adults and children)

-Amblyopia ("lazy eye")

-Pterygium surgery ("nail" or "palm")

Diseases treated

-Amblyopia

-Central serous choroidopathy

-Pterygium

-Macular edema

-Strabismus

-Keratoconus

-Dry eye syndrome

-Dropped eyelids

-Corneal trauma

-Glaucoma

-Diabetic retinopathy

-Myopia

-Macular epiretinal membrane

-Astigmatism

-Macular degeneration spots

-Entropion

-Retinal detachment

-Corneal diseases

-Clogged nasolacrimal duct

-Presbyopia (eye strain)

-Uveitis

-Myodesopsia (floaters)

-Conjunctivitis

-Blepharitis

-Farsightedness

-Age-related macular degeneration

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Dr. José Miguel Esteban López-Jamar is a gastroenterologist. He has led the Digestive Endoscopy and Digestive Diseases Units at Hospital Ruber Internacional since 2007. He has more than 20 years of experience. He is a Spanish pioneer in endoscopic ultrasound (EUS). His work covers diagnostic and interventional endoscopy. He uses innovative, minimally invasive techniques for complex gastrointestinal disease.

He was Head of Endoscopy (2008–2012) and Head of Endoscopic Innovation (2012–2014) at Hospital Clínico San Carlos. He completed international training at AMC Amsterdam, Institut Paoli-Calmettes in Marseille, and Zhongshan Hospital in Shanghai. He holds an MD and a PhD from the Complutense University of Madrid. He is a specialist in gastroenterology. He takes part in multicenter European studies and clinical trials. He is a member of SEPD, SEED, and ESGE.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

The doctor is a pediatric epileptologist with 30 years of experience, specializing in the medical and surgical treatment of childhood epilepsy, cognitive development disorders, and emotional regulation in focal forms of the disease.

Currently, the doctor coordinates the Epilepsy Program at Sant Joan de Déu Children's Hospital in Barcelona and heads the Epilepsy, Sleep Disorders and Pediatric Neurophysiology Unit at the University Hospital of Lyon.

Involved in clinical research, the doctor focuses on drug and surgical treatment of epilepsy, genetic features of epilepsy in children, and brain disorders associated with focal epilepsy.

The doctor serves as a staff physician in the Epilepsy Group at the Department of Child Neurology, Hospital Sant Joan de Déu.

Additionally, the doctor is a Clinical Research Assistant in the Department of Epilepsy, Sleep and Neurofunctional Research in Children, contributing to advancements in pediatric neurology.

The doctor is a children's ophthalmologist with a specialization in the treatment of retinoblastoma. With extensive experience in pediatric eye care, the doctor focuses on the diagnosis and management of this rare eye cancer, employing advanced techniques to improve patient outcomes. The doctor is committed to research and innovation in the field, contributing to advancements in treatment protocols and patient care standards.

Pediatric orthopedist-traumatologist, specializes in surgical oncology

15 years of experience

• 
  
• He passed specialization in orthopedic surgery and traumatology at the Children's Research Hospital of St. Jude in Memphis, USA (2007-2008).
• Dr. Thorner Rubins currently teaches at the University of Barcelona.
• Нe is the head of the Department of Orthopedics and Traumatology at the Hospital Sant Joan de Déu in Barcelona.

The doctor is a pediatric ophthalmologist with over 20 years of experience, specializing in congenital cataracts and pediatric anterior segment surgery. Since 1996, the doctor has been a specialist in ophthalmology at Sant Joan De Déu-Barcelona Children’s Hospital.

The doctor graduated from Barcelona University with a degree in general medicine and surgery in 1991 and completed a specialty in ophthalmology at the Hospital Clinic of Barcelona in 1996. Since 2013, the doctor has been involved in teaching at Hospital Sant Joan de Déu Barcelona.

The doctor is a member of The Catalan Society of Ophthalmology, The Spanish Strabology Society, and The European Paediatric Ophthalmological Society.

Dr. Jose Hinojosa Mena-Bernal is a Spanish pediatric neurosurgeon. He specializes in neuro-oncology, neuroendoscopy, maxillofacial, and minimally invasive surgery. He leads the Neurosurgery Department at Sant Joan De Déu Children’s Hospital. Dr. Hinojosa has also held leadership positions at other major hospitals in Spain.

He has written 93 scientific papers. Dr. Hinojosa works as an editor and reviewer for leading neurosurgical journals. He is President of the Spanish Society of Pediatric Neurosurgery. He is also an active member of international groups such as ISPN and EANS. His roles show his strong reputation and influence in pediatric neurosurgery.

The doctor is an oncosurgeon with 25 years of experience, specializing in rectal and colon cancer treatment, bariatric surgery, and esophageal cancer treatment.

With over 15,000 surgical procedures performed, the doctor conducts more than 1,000 minimally invasive surgeries annually, utilizing laparoscopic and robotic techniques.

A member of international medical societies, the doctor is the president of the Association of Surgeons-Endoscopists in Europe and lectures on advanced surgical techniques and laparoscopy.

Renowned as a pioneer in gastrointestinal surgery, the doctor was the first to perform groundbreaking procedures such as gallbladder removal through the mouth and the first transanal total mesorectal excision (TaTME).

The doctor is a gastroenterologist with over 35 years of experience, specializing in gastrointestinal research, gut disorders, gut motility, visceral sensitivity, and intestinal gas dynamics.

Graduated from the University of Valladolid in Spain in 1977, and completed a residency in general surgery at the San Carlos University Hospital in Madrid. Further honed expertise with a three-year fellowship at the Mayo Clinic's Gastrointestinal Research Unit.

Focused on functional gastrointestinal problems, the doctor received the 1999 Janssen Award for Clinical Research in Digestive Diseases and serves as President of the European Society of Neurogastroenterology and Motility.

The doctor has focused research on paraneoplastic neurological syndromes, leading a panel that established diagnostic criteria. His work confirmed the immune hypothesis linking tumors to autoimmune neurological dysfunctions, with antibodies identified by him now essential for diagnosis.

Clinically, the doctor specializes in diagnosing and managing gliomas, primary brain lymphomas, and cancer treatment-related neurotoxicities. Recent interests include neurological complications from immune checkpoint inhibitors and hematopoietic stem cell transplantation.

He holds an MD and PhD from Universitat Autónoma de Barcelona, completed a neurology residency in Barcelona, and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center.

The doctor is a clinical scientist with expertise in the clinical application of laboratory findings in breast cancer, focusing on gene expression and molecular subtypes. The doctor designs and leads clinical trials for novel drugs and approaches at SOLTI, a Spanish breast cancer cooperative group.

Graduating with an MD from the University of Barcelona in 2003, the doctor completed a medical oncology fellowship at Vall d'Hebron Institute of Oncology and postdoctoral research at the University of North Carolina.

Currently, the doctor heads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS and is the President of SOLTI's Board of Directors. The doctor has co-founded Reveal Genomics and holds three patents.

With over 160 publications and an H-Index of 51, the doctor has been cited 13,479 times and has presented 95 communications internationally.

The doctor specializes in breast cancer and endocrine treatment, focusing on overcoming resistance to hormone therapy during adjuvant and metastatic disease. Actively involved in phase 1, 2, and 3 studies for breast cancer and melanoma, the doctor has contributed to the approval of new drugs, including cdk4/6 inhibitors like palbociclib and ribociclib for metastatic breast cancer, and immunotherapy treatments such as Pembrolizumab, Nivolumab, and Ipilimumab for melanoma. The doctor is a member of the Breast Cancer Unit and Melanoma Unit at Vall d’Hebron University Hospital and the Vall d’Hebron Institute of Oncology.

The doctor specializes in angiogenesis, DNA repair mechanisms, and immunology, serving as Principal Investigator in clinical trials for ovarian, cervical, and endometrial cancer. With a degree in Medicine and Surgery from the Complutense University of Madrid and a PhD from Universidad Autonoma de Barcelona, the doctor has published over 100 works and presentations. The doctor is a Co-Chair of the GEICO Group and a faculty member for the Gyn-Track in the European Society of Medical Oncology. Additionally, the doctor is an active member of ASCO, ESMO, and SEOM.

The doctor specializes in lymphomas and chronic lymphocytic leukemia, leading innovations in the analysis and treatment of hematological diseases. Renowned globally for expertise in Chronic Lymphocytic Leukemia (CLL), the doctor conducts significant clinical and basic research, focusing on molecular pathogenesis and new therapeutic approaches.

Currently involved in over 80 studies from phase 1 to phase 3, the doctor contributes to the development of new drugs and treatments. As Head of Hematology at the IOB Institute of Oncology and Head of the Haematology Department at Vall d’Hebron University Hospital, the doctor has published over 100 articles in prestigious journals.